Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Outlook for the Syndromic Multiplex Diagnostics Market Heading Into 2029?
In recent years, there has been a substantial growth in the size of the syndromic multiplex diagnostics market. It is projected to escalate from a value of $3.11 billion in 2024, reaching $3.43 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.0%. Factors such as the surge in demand for quick and precise diagnostic procedures, the increased knowledge concerning early detection of diseases, an upswing in hospital-acquired infections, the expanded use of molecular diagnostics, escalating healthcare expenditure, and an increased necessity for point-of-care testing have been instrumental in contributing to the historical growth period.
The market size of syndromic multiplex diagnostics is anticipated to experience considerable growth in the coming years. It is estimated to expand to $4.96 billion by 2029, with a compound annual growth rate (CAGR) of 9.7%. Factors contributing to this surge during the forecast period include escalating investments in research and development, increased utilization in settings with limited resources, growth of healthcare infrastructure in underdeveloped nations, escalating governmental initiatives for the control of infectious diseases, and an upsurge in demand for decentralized testing. The forecast period is also expected to see key trends such as the progression in multiplex polymerase chain reaction (PCR) technologies, introductions in microfluidics and lab-on-chip systems, advanced automation in processing samples, development in point-of-care molecular platforms, incorporation of cloud-based diagnostic data systems, and progress in portable diagnostic devices.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27427&type=smp
Which Factors Are Pushing The Syndromic Multiplex Diagnostics Market Forward?
The rise in infectious diseases is anticipated to boost the syndromic multiplex diagnostics market’s growth. These diseases are brought on by harmful microorganisms such as bacteria, viruses, fungi, or parasites that infest the body and proliferate, leading to symptoms and health issues. The growth in infectious diseases is propelled by increased worldwide travel, which speeds up the distribution of pathogens across territories and populations. Syndromic multiplex diagnostics augment the management of infectious diseases by providing quick and concurrent detection of numerous pathogens from a single sample. This enhances diagnostic precision and speed, enabling prompt treatment decisions and enhanced patient results. For example, in March 2023, the Centers for Disease Control and Prevention, a US-based national public health organization, reported 8,331 tuberculosis (TB) cases in 2022, a 5.9% rise from 7,874 cases in 2021. Consequently, the escalating prevalence of infectious diseases is contributing to the growth of the syndromic multiplex diagnostics market.
Which Segment Held The Largest Share In The Syndromic Multiplex Diagnostics Market In 2025?
The syndromic multiplex diagnostics market covered in this report is segmented
1) By Product Type: Instruments, Reagents, Software And Services
2) By Sample Type: Blood Samples, Urine Samples, Saliva Samples, Tissue Samples
3) By Technology: Polymerase Chain Reaction, Mass Spectrometry, Nucleic Acid Amplification Tests, Next-Generation Sequencing
4) By Application: Infectious Diseases, Respiratory Diseases, Gastrointestinal Diseases, Sexually Transmitted Infections, Central Nervous System Diseases
5) By End User: Clinical Laboratories, Hospitals, Pharmaceutical And Biotechnology Companies, Research Institutes, Other End Users
Subsegments:
1) By Instruments: Real-Time Polymerase Chain Reaction (PCR) Systems, Microfluidic-Based Systems, Automated Sample-To-Answer Systems, Cartridge-Based Systems, Multiplex Polymerase Chain Reaction (PCR) Platforms
2) By Reagents: Assay Panels, Primers And Probes, Enzymes, Buffers And Solutions, Sample Preparation Reagents
3) By Software And Services: Data Analysis Software, Cloud-Based Diagnostic Platforms, Integration And Connectivity Solutions, Technical Support Services, Maintenance And Calibration Services, Training And Installation Services
How Are Key Trends Driving Expansion In The Syndromic Multiplex Diagnostics Industry?
Prominent firms in the syndromic multiplex diagnostics sector are concentrating on creating high-tech solutions, such as AI-boosted diagnostic systems, to increase the pace, precision, and comprehensiveness of disease-causing agent detection. Advanced computational tools that apply artificial intelligence, specifically machine learning and deep learning approaches, to interpret intricate clinical and lab data for quicker and more precise disease detection are referred to as AI-boosted diagnostic systems. For example, Qiagen N.V., a company specialising in molecular diagnostics located in the Netherlands, introduced two syndromic testing panels for its QIAstat Dx platform in January 2024: the Gastrointestinal Panel 2 and the Meningitis and Encephalitis Panel. These panels facilitate prompt and precise diagnosis of infectious diseases by identifying multiple pathogens in one test, thereby enhancing clinical judgment and patient results. The QIAstat-Dx system includes progressive data analytics, assisting healthcare professionals in effectively recognising and handling infectious disease outbreaks.
Which Organizations Are Driving Progress In The Syndromic Multiplex Diagnostics Industry?
Major companies operating in the syndromic multiplex diagnostics market are Roche Molecular Systems Inc., Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Cepheid, Bosch Healthcare Solutions GmbH, Biocartis NV, Luminex Corporation, Curetis GmbH, Accelerate Diagnostics Inc., Applied BioCode Inc., Ador Diagnostics Ltd., Akonni Biosystems Inc., Alveo Technologies Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, Nanomix Inc., Primerdesign Ltd.
Get The Full Report Here:
Which Region Is Expected To Experience The Highest Growth In The Syndromic Multiplex Diagnostics Industry?
North America was the largest region in the syndromic multiplex diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the syndromic multiplex diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27427&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model